# Metabolic Responses to Spermidine Supplementation.

> **NCT05459961** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Chrysea Labs Lda** · enrollment: 42 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DIETARY_SUPPLEMENT:** oral spermidine

## Key facts

- **NCT ID:** NCT05459961
- **Lead sponsor:** Chrysea Labs Lda
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-14
- **Primary completion:** 2023-12-25
- **Final completion:** 2025-02
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2024-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05459961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05459961, "Metabolic Responses to Spermidine Supplementation.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05459961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*